Cardiac Ambulatory Monitoring Market Report 2025

This Cardiac Ambulatory Monitoring market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The cardiac ambulatory monitoring market size has grown strongly in recent years. It will grow from $14.17 billion in 2024 to $14.97 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth during the historical period can be attributed to the increasing prevalence of cardiovascular diseases, greater awareness of heart health, the rising use of wearable devices, an aging population, and a stronger emphasis on outpatient care and remote monitoring.

The cardiac ambulatory monitoring market size is expected to see strong growth in the next few years. It will grow to $18.6 billion in 2029 at a compound annual growth rate (CAGR) of 5.6%. Looking ahead, growth during the forecast period is expected to be driven by the rise of personalized healthcare approaches, greater adoption of mobile health applications, improvements in telemedicine infrastructure, higher healthcare spending, and government support for preventive healthcare initiatives. Key trends in the forecast period include the use of artificial intelligence (AI)-driven predictive analytics, the integration of cloud solutions, the miniaturization of monitoring devices, the incorporation of real-time data analysis with wearables, and advancements in battery technology for continuous monitoring.

The increasing prevalence of cardiovascular disease is expected to drive the growth of the cardiac ambulatory monitoring market. Cardiovascular disease (CVD) encompasses various conditions that affect the heart and blood vessels, including heart attacks, strokes, and heart failure. These diseases typically result from blockages in blood vessels or irregularities in heart function. Contributing factors include poor diet, lack of exercise, smoking, stress, and an aging population. Additionally, conditions such as obesity, diabetes, and hypertension are amplifying the incidence of CVD. Cardiac ambulatory monitoring enables continuous tracking of heart activity, which helps detect irregularities early in patients with cardiovascular conditions. This approach allows for more effective management of heart issues by facilitating real-time diagnosis and monitoring, reducing the need for frequent hospital visits. For example, according to the British Heart Foundation in September 2024, approximately 7.6 million people in the UK are currently affected by heart and circulatory diseases, including 4 million men and 3.6 million women. By 2030, the number of affected individuals could rise by 1 million, and by 2040, it could increase by an additional 2 million. As such, the growing prevalence of cardiovascular diseases is propelling the cardiac ambulatory monitoring market.

Companies in the cardiac ambulatory monitoring market are focusing on developing innovative technologies such as artificial intelligence (AI) and Bluetooth-enabled electrocardiogram devices to improve patient monitoring and data accuracy. These advanced tools use AI algorithms for real-time heart data analysis and Bluetooth technology to wirelessly transmit the information to healthcare providers. In September 2024, AliveCor Inc., a US-based company offering remote cardiac care, launched the KardiaMobile Card. This portable device allows users to monitor their heart health in real time, particularly for detecting arrhythmias and managing heart conditions directly from their wallet. The KardiaMobile Card makes heart health data easily accessible, promoting early detection of heart issues and helping to reduce the economic impact of cardiovascular diseases.

In May 2024, WearLinq Inc., a US-based provider of wearable health monitoring solutions, acquired AMI Cardiac Monitoring LLC for an undisclosed amount. This acquisition is set to enhance WearLinq's nationwide clinical services and expand access to its FDA-cleared eWave 6-lead wearable ECG monitor. This move strengthens the company’s position in the cardiac diagnostics market, establishing it as a key player. AMI Cardiac Monitoring LLC is an independent US-based diagnostic testing facility specializing in ambulatory cardiac monitoring.

Major players in the cardiac ambulatory monitoring market are Abbott Laboratories, Medtronic PLC, Becton, Dickinson and Company, Koninklijke Philips N.V., GE Healthcare, Boston Scientific Corporation, Hill-Rom Holdings Inc., Nihon Kohden Corporation, MicroPort Scientific Corp., Fukuda Denshi Co. Ltd., iRhythm Technologies Inc., ZOLL Medical Corporation, Schiller AG, Biotronik SE & Co. KG, Medicomp Inc., Applied Cardiac Systems, Bardy Diagnostics Inc., ACS Diagnostics Inc., WebCardio LLC, ReactDx.

North America was the largest region in the cardiac ambulatory monitoring market in 2024. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the cardiac ambulatory monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Cardiac ambulatory monitoring involves the continuous tracking and evaluation of a patient's heart activity while they engage in their everyday activities outside of a clinical environment. This monitoring is commonly used to identify arrhythmias, assess the effectiveness of cardiac treatments, and evaluate heart health over a prolonged period.

The primary types of cardiac ambulatory monitoring include electrocardiogram (ECG) devices, Holter monitors, event monitors, implantable loop recorders, and mobile cardiac telemetry. Electrocardiogram (ECG) devices are medical tools that record the heart's electrical activity, offering vital information for diagnosing cardiac issues. Within this field, there are both single-specialty and multi-specialty practices. The key users of these monitoring devices are hospitals, ambulatory surgical centers, specialty clinics, cardiac care centers, and home care environments.

The cardiac ambulatory monitoring market research report is one of a series of new reports that provides cardiac ambulatory monitoring market statistics, including the cardiac ambulatory monitoring industry's global market size, regional shares, competitors with a cardiac ambulatory monitoring market share, detailed cardiac ambulatory monitoring market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac ambulatory monitoring industry. This cardiac ambulatory monitoring market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cardiac ambulatory monitoring market consists of revenues earned by entities by providing services such as holter monitoring, patch electrocardiogram monitoring, mobile cardiac telemetry (MCT), and wireless remote monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiac ambulatory monitoring market also includes sales of remote patient monitoring systems, wearable fitness trackers, and cardiac rehabilitation monitors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.